DXPE Director Receives 917-Share Grant at $90.04 – Insider Form 4
DXP Enterprises Inc. (DXPE) filed a Form 4 disclosing that director Karen Hoffman received a grant of 917 shares of common stock on 1 July 2025.
Rhea-AI Filing Summary
DXP Enterprises Inc. (DXPE) filed a Form 4 disclosing that director Karen Hoffman received a grant of 917 shares of common stock on 1 July 2025. The shares were recorded at an acquisition price of $90.04 and will fully vest one year from the grant date, per the filing’s footnote. Following the transaction, Hoffman’s direct ownership increased to 7,186 shares. No derivative transactions were reported and the filing was made individually by the director.
Positive
- None.
Negative
- None.
Insights
TL;DR: Small insider grant; signals alignment but immaterial to valuation.
The reported transaction is a routine director equity grant totaling roughly $82k (917 shares × $90.04). While insider acquisitions can indicate confidence, the position size is modest relative to DXPE’s market capitalization and trading volume. No open-market purchase, sale, or option exercise occurred, and there is no change in control or governance. Consequently, the disclosure is neutral for valuation and liquidity, though it marginally strengthens director-shareholder alignment. Impact: Not impactful.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | DXP Common Stock | 917 | $90.04 | $83K |
Footnotes (1)
- F1. The term of the grant provide for full vesting one year from the date of grant. [Grant date July 1, 2025 - 917 shares]
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did DXPE report on Form 4 dated July 7 2025?
Does the Form 4 include any derivative security transactions for DXPE?
Is this DXPE Form 4 filing made by more than one reporting person?
AI-generated analysis. How Rhea-AI works. Not financial advice.